Emerging evidence suggests that GLP1 therapy can: Reduce hepatic fat content, as shown in MRI-PDFF studies Lower markers of liver inflammation and fibrosis Improve insulin sensitivity and metabolic control Although most trials focus on obese or diabetic populations, livercentric endpoints are increasingly evaluated, and benefits appear to extend beyond weight loss alone
I'm down 14lbs and 3% body fat
The two peptides differ on every axis that matters for protocol design: origin, structural class, mechanism, the repair-cascade window they appear to act on, and the strength of the underlying evidence
Individualized Treatment Plans: Healthcare providers should tailor treatment plans based on an individuals unique health status, medication history, and goals
#WeightLossJourney #Semaglutide #NovuskinLasVegas #TransformationTuesday #HealthGoals #FitnessMotivation #WellnessJourney #WeightLossSupport #Inspiration #BodyTransformation #HealthyLiving #FitnessGoals #SelfCare #HealthyLifestyle #LasVegas #FitnessJourney #DietAndExercise #WellnessClinic #MotivationMonday #JourneyToHealth | Novuskin Med Spa
This study is also reported in accordance with ARRIVE guidelines